An analysis on the evolution of the regulation system of drug registration in China——base on text miningLI Shu-xiang, CHU Shu-zhen, ZHUANG Qian1-8
Post-authorization safety study in European Union and its enlightenment to ChinaZHANG Qi, YAN Jian-zhou, YAO Wen, SHAO Rong9-14
Patent analysis of HDAC inhibitor chidamideCHI Li-na, YUAN Yue, ZHOU Fu-ke, GUO Xiao-yun, WANG Qin-geng15-21
The main concerns in reproductive and developmental toxicity studies of human pharmaceuticals during the implementation of ICH M3 (R2) guidanceHUANG Fang-hua, WANG Qing-li, WANG Hai-xue, HAN Ling22-26
Gene transduction systems in cellular therapy products and points to IND reviewLU Jia-qi, WEI Wei, BAI Yu, LUO Jian-hui27-32
Analysis on the status quo and problems of the development of new drugs in ChinaAO Yi, PU Run, ZHAN Yong, SUN Yan-rong33-41
Development and validation of determination of free and total IgE in cynomolgus monkey serumSUN Xiao-hui, MAN Su-qin, CHEN Ya-hui, CHEN Ju-bing, ZHU Xi, ZHAO Xiao-ping, CHENG Yuan-guo, MA Jing42-47
The neuroprotective effect and mechanism identification of xanthone extract from Swertia punicea Hemsl on the MPTP-induced Parkinson's disease in mouseGAO Ze-yu, GUO Yong-fei, SUN Yi, LIN Ming, PU Xiao-ping, ZHAO Xin48-54
Application of new formulations in ocular drug delivery systemZHOU Xiang-ying, LI Jia-li, WANG Ya-min, CAO Feng55-62
Bioequivalence of azilsartan tablets in Chinese healthy volunteersCAO Duan-wen, LI Pu, ZUO Rong, LIU Xiao-jian, HU Jin-fang, WEI Xiao-hua63-68